These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7825802)

  • 1. Cytokine antagonists in infectious and inflammatory disorders.
    Catania A; Manfredi MG; Airaghi L; Ceriani G; Gandino A; Lipton JM
    Ann N Y Acad Sci; 1994 Nov; 741():149-61. PubMed ID: 7825802
    [No Abstract]   [Full Text] [Related]  

  • 2. Interleukin-1.
    Dinarello CA
    Adv Pharmacol; 1994; 25():21-51. PubMed ID: 8204502
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibitory cytokines and cytokine inhibitors.
    Burger D; Dayer JM
    Neurology; 1995 Jun; 45(6 Suppl 6):S39-43. PubMed ID: 7783910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokines and natural regulators of cytokines.
    Bendtzen K
    Immunol Lett; 1994 Dec; 43(1-2):111-23. PubMed ID: 7737681
    [No Abstract]   [Full Text] [Related]  

  • 5. Soluble receptors and cytokine antagonists in human milk.
    Buescher ES; Malinowska I
    Pediatr Res; 1996 Dec; 40(6):839-44. PubMed ID: 8947960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine neutralizing strategies in experimental sepsis.
    Enayati P; Fong Y
    Prog Clin Biol Res; 1994; 388():295-306. PubMed ID: 7831365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proinflammatory and anti-inflammatory cytokines as mediators in the pathogenesis of septic shock.
    Dinarello CA
    Chest; 1997 Dec; 112(6 Suppl):321S-329S. PubMed ID: 9400897
    [No Abstract]   [Full Text] [Related]  

  • 8. [Evidence-based treatment of methotrexate-resistant rheumatoid arthritis. Cytokine antagonists].
    Schnabel A; Gross WL
    Dtsch Med Wochenschr; 2003 Jan; 128(5):201-3. PubMed ID: 12557112
    [No Abstract]   [Full Text] [Related]  

  • 9. Relative cytokine and cytokine inhibitor production by mononuclear cells and neutrophils.
    Xing L; Remick DG
    Shock; 2003 Jul; 20(1):10-6. PubMed ID: 12813362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The biological role of naturally-occurring cytokine inhibitors.
    Arend WP; Malyak M; Bigler CF; Smith MF; Janson RW
    Br J Rheumatol; 1991; 30 Suppl 2():49-52. PubMed ID: 1847086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of interleukin-1 receptor antagonist (IL-1RA) and tumor necrosis factor binding protein (TNF-BP) in a rodent abscess model of host resistance.
    Colagiovanni DB; Shopp GM
    Immunopharmacol Immunotoxicol; 1996 Aug; 18(3):397-419. PubMed ID: 8872492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mode of action of cytokine inhibitors.
    Arend WP
    J Rheumatol Suppl; 2002 Sep; 65():16-21. PubMed ID: 12236617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma concentration of cytokine antagonists in patients with HIV infection.
    Catania A; Manfredi MG; Airaghi L; Vivirito MC; Capetti A; Milazzo F; Lipton JM; Zanussi C
    Neuroimmunomodulation; 1994 Jan; 1(1):42-9. PubMed ID: 8528884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating interleukin-1 and tumor necrosis factor antagonists in liver disease.
    Tilg H; Vogel W; Wiedermann CJ; Shapiro L; Herold M; Judmaier G; Dinarello CA
    Hepatology; 1993 Nov; 18(5):1132-8. PubMed ID: 8225219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyloid-beta peptide induced inflammatory reaction is mediated by the cytokines tumor necrosis factor and interleukin-1.
    Sutton ET; Thomas T; Bryant MW; Landon CS; Newton CA; Rhodin JA
    J Submicrosc Cytol Pathol; 1999 Jul; 31(3):313-23. PubMed ID: 10626000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticytokine strategies in the treatment of the systemic inflammatory response syndrome.
    Dinarello CA; Gelfand JA; Wolff SM
    JAMA; 1993 Apr; 269(14):1829-35. PubMed ID: 8459516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of interleukin 1 in infection and sepsis].
    Beuscher HU; Rausch UP; Röllinghoff M
    Immun Infekt; 1992 Aug; 20(4):128-33. PubMed ID: 1398733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell density regulates neutrophil IL-8 synthesis: role of IL-1 receptor antagonist and soluble TNF receptors.
    Hattar K; Fink L; Fietzner K; Himmel B; Grimminger F; Seeger W; Sibelius U
    J Immunol; 2001 May; 166(10):6287-93. PubMed ID: 11342652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific cytokine regulators and their therapeutic potentials--an overview.
    Kashiwagi H; Suzuki H
    Intern Med; 1992 Nov; 31(11):1245-9. PubMed ID: 1295618
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of interleukin-1 receptor antagonist and soluble tumor necrosis factor receptor in animal models of infection.
    París MM; Friedland IR; Ehrett S; Hickey SM; Olsen KD; Hansen E; Thonar EJ; McCracken GH
    J Infect Dis; 1995 Jan; 171(1):161-9. PubMed ID: 7798656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.